Skip to content

Commit

Permalink
Update _index.md
Browse files Browse the repository at this point in the history
Changed the admin details to match the author name in publications
  • Loading branch information
chlazaris authored Jan 3, 2024
1 parent 1c599f0 commit 81f03d8
Showing 1 changed file with 2 additions and 2 deletions.
4 changes: 2 additions & 2 deletions content/authors/admin/_index.md
Original file line number Diff line number Diff line change
@@ -1,6 +1,6 @@
---
# Display name
title: Charalampos A. Lazaris
title: Charalampos Lazaris

# Name pronunciation (optional)
name_pronunciation:
Expand Down Expand Up @@ -136,5 +136,5 @@ social:
highlight_name: true
---

Charalampos Lazaris is a member of the Oncology Data Science team at Novartis Biomedical Research in Cambridge, MA. He explores mechanisms of transcriptional regulation in order to uncover cancer vulnerabilities and target them therapeutically. He earned his Ph.D. at the NYU School of Medicine, under the supervision of Drs. Iannis Aifantis and Aristotelis Tsirigos. During his Ph.D., he focused on genetic alterations of topologically associating domain (TAD) boundaries and their link with aberrant oncogene activation in T-cell acute lymphoblastic leukemia, a type of blood cancer common in children. He completed postdoctoral work at the USC Keck School of Medicine and the Whitehead Institute (MIT). He was also an Associated Scientist at the Klarman Cell Observatory of the [Broad Institute of MIT and Harvard](https://www.broadinstitute.org). While at Broad Institute, he served as a vice-chair of the NextGen Association. He currently serves as the President of the New York University Graduate School of Arts and Science Doctoral Alumni Association ([DAA](https://gsas.nyu.edu/student-life/doctoral-alumni-association.html)).
Dr. Charalampos Lazaris is a member of the Oncology Data Science team at Novartis Biomedical Research in Cambridge, MA. He explores mechanisms of transcriptional regulation in order to uncover cancer vulnerabilities and target them therapeutically. He earned his Ph.D. at the NYU School of Medicine, under the supervision of Drs. Iannis Aifantis and Aristotelis Tsirigos. During his Ph.D., he focused on genetic alterations of topologically associating domain (TAD) boundaries and their link with aberrant oncogene activation in T-cell acute lymphoblastic leukemia, a type of blood cancer common in children. He completed postdoctoral work at the USC Keck School of Medicine and the Whitehead Institute (MIT). He was also an Associated Scientist at the Klarman Cell Observatory of the [Broad Institute of MIT and Harvard](https://www.broadinstitute.org). While at Broad Institute, he served as a vice-chair of the NextGen Association. He currently serves as the President of the New York University Graduate School of Arts and Science Doctoral Alumni Association ([DAA](https://gsas.nyu.edu/student-life/doctoral-alumni-association.html)).
{style="text-align: justify;"}

0 comments on commit 81f03d8

Please sign in to comment.